Jin Jian Huang
Director of Finance/CFO bei CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
Profil
Jin Jian Huang is currently the Director at QYH Biotech Co., Ltd.
and the Chief Financial & Accounting Officer at China Animal Husbandry Industry Co., Ltd.
He previously worked as a Director at Xiamen Kingdomway Group Co. and as the Board Secretary & Chief Accountant at Zhongnongfa Seed Industry Group Co., Ltd.
Mr. Huang obtained an undergraduate degree from Anhui Finance & Trade College.
Aktive Positionen von Jin Jian Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. | Director of Finance/CFO | 31.08.2018 |
QYH Biotech Co., Ltd.
 QYH Biotech Co., Ltd. BiotechnologyHealth Technology QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jin Jian Huang
| Unternehmen | Position | Ende |
|---|---|---|
| ZHONGNONGFA SEED INDUSTRY GROUP CO., LTD. | Comptroller/Controller/Auditor | 31.08.2018 |
| XIAMEN KINGDOMWAY GROUP COMPANY | Director/Board Member | - |
Ausbildung von Jin Jian Huang
| Anhui Finance & Trade College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ZHONGNONGFA SEED INDUSTRY GROUP CO., LTD. | Distribution Services |
| CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. | Health Technology |
| XIAMEN KINGDOMWAY GROUP COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
QYH Biotech Co., Ltd.
QYH Biotech Co., Ltd. BiotechnologyHealth Technology QYH Biotech Co., Ltd. engages in the research, development, and production of vaccines for major animal diseases such as highly pathogenic avian influenza and highly pathogenic swine blue ear disease. The company was founded on July 1, 2004 and is headquartered in Beijing. | Health Technology |
